510(k) · Cleared
Recalled · Class I · 2026Alaris Medical Infusion System Administration Sets
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Alaris Medical Systems, Inc. · FPA Set, Administration, Intravascular
Cleared on Aug 6, 2002 after a 29-day review. The FDA summary names no predicate by number. 1 of the 4 devices in its family, counting itself, has a Class I recall. 3 later devices descend from it. It has been recalled 8 times, including 3 Class I recalls.
- Decided
- Aug 6, 2002
- Review
- 29 days
- Class
- Class II
- Product code
- FPA
- Recalls
- 8 (3 Class I)
- Predicates
- 0
3 later devices descend from it, 2 citing it directly. 1 of the 4 devices in this family, counting this one, has a Class I recall.
- This deviceK022209 Alaris Medical Infusion System Administration SetsAlaris Medical Systems, Inc. · 2002
- Descendant · cites it directly · 1 of its ownK221327 BD Alaris™ Pump Infusion SetsCare Fusion · 2023
- Descendant · 2 generations on · 0 of its ownK250325 BD Alaris Pump Infusion SetCarefusion (Bd) · 2025
- Descendant · cites it directly · 0 of its ownK041919 Perfudrop Air M-P with Needle 20 G, Model 48451606Clinico · 2004
Most influential descendants
Showing 3 of 3 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K022209 | Alaris Medical Infusion System Administration Sets | Alaris Medical Systems, Inc. | 2002 | — |
| +1 | K221327 | BD Alaris™ Pump Infusion Sets | Care Fusion | 2023 | — |
| +2 | K250325 | BD Alaris Pump Infusion Set | Carefusion (Bd) | 2025 | — |
| +1 | K041919 | Perfudrop Air M-P with Needle 20 G, Model 48451606 | Clinico | 2004 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2004 | 1 | 0 |
| 2023 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FPA device
- #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
The FDA summary names no predicate by number.
What descends from it? (3)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (1 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Aug 19, 2026 | Class I | Z-3080-2026 | Device Design | Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance. |
| Sep 11, 2025 | Class I | Z-0035-2026 | Under Investigation by firm | Infusion pump module used with compatible pump infusion sets may perform outside the established performance ranges for flow rate and bolus accuracy, downstream and upstream occlusion time to alarm, and post-occlusion bolos volume. |
| Jul 8, 2025 | Class I | Z-2180-2025 | Under Investigation by firm | Infusion pump module used with compatible pump infusion sets may perform outside the established performance ranges for flow rate and bolus accuracy, downstream and upstream occlusion time to alarm, and post-occlusion bolos volume. |
| Apr 18, 2024 | Class II | Z-1944-2024 | Process control | Due to infusion set tubing drip chamber becoming detached from the tubing potentially causing delays in treatment, or unintentionally exposing users to harsh infusates. |
| Oct 11, 2023 | Class II | Z-0349-2024 | Error in labeling | Affected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP). |
| Oct 11, 2023 | Class II | Z-0350-2024 | Error in labeling | Affected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP). |
| Oct 11, 2023 | Class II | Z-0351-2024 | Error in labeling | Affected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP). |
| Aug 10, 2006 | Not classified | Z-1484-06 | Software design | This recall was initiated because of a potential for over infusion with all models of the Alaris SE Pumps (formerly the Signature Edition Infusion Pumps) caused by key bounce. |
The 5 latest of 8 recalls; the web page lists all.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K221327 (Care Fusion, 2023) has gone furthest, with 1 descendant of its own.
How does its category compare?
All FPA devicesFPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · FPA
11in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FPA
225in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FPA
98in 2025
Class I (17 since 2007) Class II/III not classified
Adverse event reports per year · FPA
34,506in 2025
MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 16 | 75 | 17 | 1,499 |
| 2008 | 18 | 89 | 15 | 1,941 |
| 2009 | 10 | 166 | 166 | 2,512 |
| 2010 | 23 | 120 | 58 | 2,537 |
| 2011 | 12 | 87 | 28 | 4,407 |
| 2012 | 21 | 96 | 16 (4) | 4,930 |
| 2013 | 13 | 90 | 64 | 4,651 |
| 2014 | 22 | 89 | 24 | 4,695 |
| 2015 | 17 | 123 | 6 | 6,625 |
| 2016 | 12 | 195 | 10 | 8,470 |
| 2017 | 17 | 240 | 13 | 6,462 |
| 2018 | 4 | 177 | 4 | 6,574 |
| 2019 | 7 | 161 | 13 | 11,227 |
| 2020 | 10 | 327 | 107 | 9,563 |
| 2021 | 13 | 186 | 1 | 10,414 |
| 2022 | 14 | 213 | 9 (5) | 13,393 |
| 2023 | 14 | 340 | 12 (4) | 10,916 |
| 2024 | 7 | 244 | 13 (1) | 47,210 |
| 2025 | 11 | 225 | 98 (1) | 34,506 |
| 2026 | 5 | 266 | 10 (2) | — |
What is it indicated for?
The following ALARIS Medical Infusion Systems are intended for use in today’s growing professional healthcare environment including healthcare facilities, home care, and medical transport that utilize inhsion systems for the delivery of fluids, medications, blood and blood products: IVAC? Signature Edition@Infusion Pumps and Administration Sets. IVAC? MedSystem III@Multi-Channel Inhsion Pump and IVAC MedSystem I I P Multi-Channel Infusion Pump with DLE…
Read the full statement (87 words)
The following ALARIS Medical Infusion Systems are intended for use in today’s growing professional healthcare environment including healthcare facilities, home care, and medical transport that utilize inhsion systems for the delivery of fluids, medications, blood and blood products:
IVAC? Signature Edition@Infusion Pumps and Administration Sets.
IVAC? MedSystem III@Multi-Channel Inhsion Pump and IVAC MedSystem I I P Multi-Channel Infusion Pump with DLE and Administration Sets.
IMED@Gemini Infusion Pumps/Controllers and Administration Sets.
ALARIS Medical Medley” Medication Safety System and Administration Sets.
IVAC@,IMED@,and ALARIS@Gravity, Extension, Components, and Secondary Administration Sets.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K022209 · printed Nov 6, 2026
Cite this page
510(k) Report. “K022209: Alaris Medical Infusion System Administration Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K022209
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026